Revision bariatric surgery is a specialized subspecialty within metabolic and gastrointestinal surgery designed to treat failure or complications of primary bariatric operations. The primary goals are to re-establish physiological weight loss, resolve metabolic co-morbidities, and correct structural defects such as pouch dilation, staple-line disruption, or hardware failure. Depending on the patient's specific anatomical and metabolic profile, procedures range from simple hardware removal to complex conversion surgeries that alter intestinal nutrient absorption and gut hormone signaling.

Revision bariatric surgery is performed under general anesthesia using laparoscopic or robotic-assisted techniques over 2 to 4 hours. The surgical team initiates the procedure by establishing pneumoperitoneum and placing specialized trocars. Surgeons perform careful adhesiolysis to free scar tissue surrounding the stomach and liver. Once original anatomical landmarks are identified, the surgeon executes the tailored revision—such as removing a gastric band, re-stapling a dilated gastric pouch, or creating a new gastrojejunal anastomosis. Intraoperative leak testing using air or dye confirmation is conducted prior to port closure and patient emergence.

Evidence-based clinical advantages of revision bariatric surgery include:

• Secondary Weight Loss: Secondary excess weight loss averages between 40% and 65% over 12 to 24 months post-revision, depending on the procedural type.
• Resolution of Reflux: Conversion to Roux-en-Y gastric bypass provides definitive relief for over 80% to 90% of patients with severe post-sleeve GERD.
• Metabolic Disease Improvement: Re-establishment of gut hormone alterations promotes renewed glycemic control in patients with recurrent type 2 diabetes.
• Correction of Mechanical Defects: Complete structural resolution of band erosions, slippage, pouch dilations, and chronic outlet strictures.
• Enhanced Quality of Life: Significant improvements in functional mobility, self-image, and gastrointestinal symptom scores.

Short-term recovery involves an inpatient stay of 1 to 3 days focused on pain control, early ambulation, and oral hydration. Patients follow a strict liquid diet for 2 weeks, transitioning to puréed foods for 2 weeks, and soft solids by week 5. Light activities resume within 10 to 14 days, while heavy lifting and strenuous exercise are restricted for 4 to 6 weeks. Long-term recovery requires lifelong daily micronutrient supplementation, regular protein intake monitoring, and routine clinical follow-up at 1, 3, 6, and 12 months, followed by annual multidisciplinary evaluations.

Revision bariatric surgery treats secondary metabolic and structural failure following primary weight loss operations. Specific indications include:

• Weight Regain: Significant accumulation of weight following initial success due to hormonal blunting or anatomical dilation.
• Inadequate Weight Loss: Failure to lose at least 50% of excess body weight post-primary operation.
• Severe Gastroesophageal Reflux Disease (GERD): Intractable acid reflux and esophagitis, particularly following vertical sleeve gastrectomy.
• Hardware Complications: Slippage, erosion, or tissue ischemia associated with adjustable gastric bands.
• Anatomical Defects: Gastric pouch expansion, gastrojejunostomy outlet dilation, or staple-line disruption.
• Chronic Surgical Complications: Persistent marginal ulceration, recurrent gastrointestinal strictures, or chronic dumping syndrome.

Pre-operative preparation requires a comprehensive diagnostic evaluation, including upper gastrointestinal endoscopy (EGD) to inspect the mucosal lining, an upper GI fluoroscopic swallow study to evaluate stomach volume and motility, and blood panels to detect micronutrient deficiencies. Patients undergo psychological and dietary evaluations to confirm post-operative readiness. Two weeks prior to surgery, patients start a high-protein, low-carbohydrate liquid diet to reduce liver size and abdominal fat, minimizing surgical risk. Smoking and non-steroidal anti-inflammatory drugs (NSAIDs) must be stopped at least 4 to 6 weeks pre-operatively.

Complications are stratified by frequency and severity. Common, minor risks include transient post-operative nausea, port-site bruising, and temporary difficulty swallowing (dysphagia). Less common risks include surgical wound infection, marginal ulceration at the staple line, and gastrointestinal strictures requiring endoscopic dilation. Rare but serious complications include anastomotic or staple-line leaks (1%–3%), deep vein thrombosis, pulmonary embolism, internal herniation, and severe micronutrient malabsorption requiring specialized intravenous replacement.

The clinical journey for revision bariatric surgery begins with an extensive multidisciplinary diagnostic workup, including upper gastrointestinal endoscopy, fluoroscopic swallow studies, and micronutrient assessment. Once anatomical failure or metabolic relapse is confirmed, the patient undergoes pre-operative dietary optimization to decrease liver volume. The surgical procedure is conducted under general anesthesia using minimally invasive techniques, typically requiring a 1- to 3-day inpatient hospital stay. Post-operative recovery involves a progressive liquid-to-solid dietary protocol, regular physical activity resumption within 4 to 6 weeks, and lifelong clinical follow-up with specialized metabolic and nutritional monitoring.